Personalized medicine: new genomics, old lessons

Por Offit, Kenneth
Publicado em 2011

The Future of Clinical Cancer Genomics

Por Offit, Kenneth
Publicado no Semin Oncol (2016)

Heterozygous Mutations in DNA Repair Genes and Hereditary Breast Cancer: A Question of Power

Por Ellis, Nathan A., Offit, Kenneth
Publicado em 2012

Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?

Por Storm, Courtney, Agarwal, Rinki, Offit, Kenneth
Publicado em 2008

Association of a HOXB13 Variant with Breast Cancer

Por Alanee, Shaheen, Couch, Fergus, Offit, Kenneth
Publicado em 2012

Revealing the Incidentalome When Targeting the Tumor Genome

Por Bombard, Yvonne, Robson, Mark, Offit, Kenneth
Publicado em 2013

Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution

Por Alanee, Shaheen, Schrader, Kasmintan, Offit, Kenneth
Publicado no Eur Urol (2015)

Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention

Por Couch, Fergus J., Nathanson, Katherine L., Offit, Kenneth
Publicado em 2014

A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing

Por Zhang, Liying, Kirchhoff, Tomas, Yee, Cindy J., Offit, Kenneth
Publicado em 2009

Genomic Biomarkers for Breast Cancer Risk

Por Walsh, Michael F., Nathanson, Katherine L., Couch, Fergus J., Offit, Kenneth
Publicado no Adv Exp Med Biol (2016)

Cancer Genomics and Inherited Risk

Por Stadler, Zsofia K., Schrader, Kasmintan A., Vijai, Joseph, Robson, Mark E., Offit, Kenneth
Publicado no J Clin Oncol (2014)

Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements

Por Hayes, James E., Trynka, Gosia, Vijai, Joseph, Offit, Kenneth, Raychaudhuri, Soumya, Klein, Robert J.
Publicado no PLoS One (2015)

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier

Por Alanee, Shaheen, Shah, Sohela, Murali, Rajmohan, Rau-Murthy, Rohini, Schrader, Kasmintan A., Offit, Kenneth
Publicado no Fam Cancer (2013)

Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology

Por Offit, Kenneth, Bradbury, Angela, Storm, Courtney, Merz, Jon F., Noonan, Kevin E., Spence, Rebecca
Publicado no J Clin Oncol (2013)

A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)

Por Ritter, Deborah I., Rao, Shruti, Kulkarni, Shashikant, Madhavan, Subha, Offit, Kenneth, Plon, Sharon E.
Publicado no Cold Spring Harb Mol Case Stud (2019)

Genetics, Genomics and Cancer Risk Assessment: State of the art and future directions in the era of personalized medicine

Por Weitzel, Jeffrey N., Blazer, Kathleen R., MacDonald, Deborah J., Culver, Julie O., Offit, Kenneth
Publicado em 2011

Variants at IRX4 as prostate cancer expression quantitative trait loci

Por Xu, Xing, Hussain, Wasay M, Vijai, Joseph, Offit, Kenneth, Rubin, Mark A, Demichelis, Francesca, Klein, Robert J
Publicado em 2014

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk

Por Kaklamani, Virginia, Yi, Nengjun, Zhang, Kui, Sadim, Maureen, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Mantzoros, Christos, Pasche, Boris
Publicado em 2011

Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk

Por Kaklamani, Virginia G., Sadim, Maureen, Hsi, Alex, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Ahsan, Habibul, Pasche, Boris, Mantzoros, Christos
Publicado em 2008

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

Por Alanee, Shaheen, Shah, Sohela, Vijai, Joseph, Schrader, Kasmintan, Rau-Murthy, Rohini, Sarrel, Kara, Manschreck, Christopher, Eastham, James, Offit, Kenneth
Publicado no Fam Cancer (2013)